Business Description
Enorama Pharma AB
ISIN : SE0008216329
Compare
Compare
Traded in other countries / regions
ERMA.Sweden IPO Date
2016-06-10Description
Enorama Pharma AB is a pharmaceutical company that focuses on consumer-friendly medicated chewing gum containing generic substances. It provides medicated gums containing generic pharmaceutical substances, developed through its ChewMed technology platform.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 28.88 | |||||
| Equity-to-Asset | 0.81 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 12.37 | |||||
| Beneish M-Score | 0.7 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -50.7 | |||||
| 3-Year EBITDA Growth Rate | 30.7 | |||||
| 3-Year EPS without NRI Growth Rate | -4.2 | |||||
| 3-Year FCF Growth Rate | 33.9 | |||||
| 3-Year Book Growth Rate | 16.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.96 | |||||
| 9-Day RSI | 41.63 | |||||
| 14-Day RSI | 40.73 | |||||
| 6-1 Month Momentum % | 55.14 | |||||
| 12-1 Month Momentum % | 59.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | |||||
| Quick Ratio | 1.76 | |||||
| Cash Ratio | 1.23 | |||||
| Days Inventory | 256.67 | |||||
| Days Sales Outstanding | 29.75 | |||||
| Days Payable | 142.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -90.7 | |||||
| Shareholder Yield % | -27.52 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 24.25 | |||||
| Operating Margin % | -238.41 | |||||
| Net Margin % | -267.3 | |||||
| FCF Margin % | -350.07 | |||||
| ROE % | -135.26 | |||||
| ROA % | -88.93 | |||||
| ROIC % | -117.24 | |||||
| ROC (Joel Greenblatt) % | -2194.55 | |||||
| ROCE % | -115.09 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 12.54 | |||||
| PB Ratio | 5.48 | |||||
| Price-to-Tangible-Book | 12.24 | |||||
| EV-to-EBIT | -5.43 | |||||
| EV-to-EBITDA | -6.06 | |||||
| EV-to-Revenue | 13.22 | |||||
| EV-to-FCF | -3.78 | |||||
| Price-to-Net-Current-Asset-Value | 12.24 | |||||
| Price-to-Net-Cash | 102 | |||||
| Earnings Yield (Greenblatt) % | -18.42 | |||||
| FCF Yield % | -25.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Enorama Pharma AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 13.299 | ||
| EPS (TTM) (kr) | -0.671 | ||
| Beta | 0 | ||
| Volatility % | 232.63 | ||
| 14-Day RSI | 40.73 | ||
| 14-Day ATR (kr) | 0.305705 | ||
| 20-Day SMA (kr) | 3.261 | ||
| 12-1 Month Momentum % | 59.77 | ||
| 52-Week Range (kr) | 2 - 8.484848 | ||
| Shares Outstanding (Mil) | 60.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Enorama Pharma AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Enorama Pharma AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Enorama Pharma AB Frequently Asked Questions
What is Enorama Pharma AB(OSTO:ERMA)'s stock price today?
The current price of OSTO:ERMA is kr3.06. The 52 week high of OSTO:ERMA is kr8.48 and 52 week low is kr2.00.
When is next earnings date of Enorama Pharma AB(OSTO:ERMA)?
The next earnings date of Enorama Pharma AB(OSTO:ERMA) is 2025-02-19.
Does Enorama Pharma AB(OSTO:ERMA) pay dividends? If so, how much?
Enorama Pharma AB(OSTO:ERMA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers